HHS Ref. No. E—256—1998/0—US—01;
HHS Ref. No. E—104—2006/0—PCT—02;
HHS Ref. No.: E-243-2012/0-IT-14 Filing Date: March 14, 2014 Current Status: Issued
HHS Ref. Nos. E—260—1994/2—EP—15, EP—16 and EP—27; HHS Ref. No. E—260—1994/2—JP—25; HHS Ref. No. E—260—1994/2—JP—21, JP—25 and JP—26; HHS Ref No. E—260—1994/2—AU—11; HHS Ref. No. E—260—1994/2—CA—12;
HHS Ref. No. E—136—2007;
HHS Ref. No.: E-097-2018-0-SG-15 Filing Date: September 9, 2020 Current status: Pending
HHS Ref. No. E-223-2000/0-EP-04: European Patent Application Ser. No. 01987684.6 (validated in France, Germany, the United Kingdom, Italy and Sweden); HHS Ref. No. E-223-2000/0-JP-07: Japanese Patent Application Ser. No. 2002-535740, HHS Ref. No. E-223-2000/0-IL-08: Israeli Patent Application Ser. No. 155320;
HHS Ref. No. E-223-2000/0-HK-09: Hong Kong Patent Application Ser. No. 03108947.4, all of which are entitled “Coil For Magnetic Stimulation” and are national phase applications of DHHS Ref. No. E-223-00/0: International Patent Application PCT/US01/50737, which claims priority from U.S. Provisional Patent Application Number 60/242,297, filed on October 20, 2000. HHS Ref. No. E-301-2007 “Summation Of TMS Stimulation Through Several Coils;” U.S. Patent Application Serial No. 11/153,905 filed June 16, 2005 and International Patent Application No. PCT/IL2006/000694 filed June 15, 2006. Licensee agrees to pay PHS earned royalties on aggregate Net Sales by or on behalf of Licensee and its sublicensees as follows: Three Percent (3%) on the portion of aggregate Net Sales up to and including Ten Million U.S. Dollars (USD$10,000,000) and Two Percent (2%) on the portion of aggregate Net Sales greater than Ten Million U.S. Dollars (USD$10,000,000). On Net Sales of Licensed Products or Licensed Processes solely within the scope of U.S. Patent Application Serial No. 11/153,905 and International Patent Application No. PCT/IL2006/000694 within the Licensed Patent Rights, the earned royalty payable will be Two Percent (2%) up to and including Net Sales of Ten Million U.S. Dollars (USD$10,000,000) and One Percent (1%) on the portion of aggregate Net Sales greater than Ten Million Dollars (USD$10,000,000).
HHS Ref. Nos. E—260—1994/1—US—03; US—02, US—01; HHS Ref. Nos. E—260—1994/1—US—04 and US—05;
HHS Ref. No. E—074—2007/0—US—07; HHS Ref. No. E—074—2007/0—AU—03; HHS Ref. No. E—074—2007/0—EP—05; HHS Ref. No. E—074—2007/0—CA—04; HHS Ref. No. E—074—2007/0—JP—06. Group II—Nonexclusive Licensed Patent Rights
